argenx NV ADR

argenx NV ADR

Yahoo Finance • 2 days ago

European Equities Traded in the US as American Depositary Receipts Edge Lower in Thursday Trading

European equities traded in the US as American depositary receipts were tracking slightly lower Thur PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 days ago

argenx (ENXTBR:ARGX) Shares Moved, So What Is Drawing Attention Now?

argenx (ENXTBR:ARGX) drew fresh attention after its Extraordinary General Meeting confirmed Thomas M. Brakel and Khurem Farooq as new non-executive directors, prompting investors to reassess how board composition might influence longer ter... Full story

Yahoo Finance • 4 days ago

These ‘Moonshot’ Biotech Stocks Could Break Out, Morgan Stanley Says. What Must Go Right.

Morgan Stanley highlights high-risk, high-reward biotech stocks poised for massive upside following key upcoming clinical readouts. Continue Reading... Full story

Yahoo Finance • 26 days ago

argenx to Present at Upcoming Investor Conferences

argenx SE September 1, 2026 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology innovation company, today announced that members of the management team will participate in the following investor conferenc... Full story

Yahoo Finance • 30 days ago

argenx (ENXTBR:ARGX) Just Gave Investors Something To Think About

argenx (ENXTBR:ARGX) is back in focus after reporting positive topline results from the ALKIVIA Phase 3 trial of VYVGART Hytrulo in autoimmune myositis, a rare muscle disease with limited targeted treatment options. argenx shares have rea... Full story

Yahoo Finance • last month

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

European equities traded in the US as American depositary receipts were tracking lower late Wednesda PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • last month

Intuit downgraded, SolarEdge upgraded: Wall Street's top analyst calls

Intuit downgraded, SolarEdge upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compile... Full story

Yahoo Finance • last month

Eli Lilly (LLY) Is Suing Six Companies Over an Unapproved Drug—Leaving Novo Nordisk (NVO) Clear in the GLP-1 Wars

On August 12, 2026, Eli Lilly and Company (NYSE:LLY) said that it filed six lawsuits against US companies it accuses of illegally selling black-market versions of retatrutide. It is an experimental obesity drug still in Phase 3 trials and... Full story

Yahoo Finance • last month

Argenx cut to hold at Deutsche Bank following share price run

[Wall Street street sign in Manhattan financial district] Alexey_Fedoren * Deutsche Bank downgraded Argenx (ARGX [https://seekingalpha.com/symbol/ARGX]) to hold from buy saying that the stock has had a nice run since it was upgraded in... Full story

Yahoo Finance • last month

European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading

European equities traded in the US as American depositary receipts started the week tracking modestl PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • last month

argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis

argenx SE Study met primary endpoint of mean Total Improvement Score (TIS) at Week 52 in the combined study population of IMNM and DM patients (p=0.0011) Patient improvements observed early and sustained throughout study; consistent treat... Full story

Yahoo Finance • last month

European Equities Traded in the US as American Depositary Receipts Track Lower in Friday Trading

European equities traded in the US as American depositary receipts were tracking lower late Friday morning, declining 0.35% to 1,962.14 on the S&P Europe Select ADR Index, which is up 0.17% for the week so far.From continental Europe, the... Full story

Yahoo Finance • 2 months ago

OmniAb Inc (OABI) (Q2 2026) Earnings Call Highlights: Revenue Surges 243% as Two Programs Leap ...

This article first appeared on GuruFocus. Release Date: August 06, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points OmniAb Inc (NASDAQ:OABI) reported a strong sec... Full story

Yahoo Finance • 2 months ago

Argenx SE (ARGX) Prepares to Demonstrate Vyvgart’s Efficacy in Broader Autoimmune Diseases

Baron Capital, an investment management company, released its Q2 2026 investor letter for the "Baron Health Care Fund". A copy of the letter is available to download here. The Fund gained 11.99% during the quarter, compared with the 10.48%... Full story

Yahoo Finance • 2 months ago

European Equities Traded in the US as American Depositary Receipts Track Sharply Higher in Thursday Trading

European equities traded in the US as American depositary receipts were tracking sharply higher late PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 2 months ago

argenx signs agreement to buy Forte Biosciences for $2.2bn

argenx has entered a definitive agreement to acquire Forte Biosciences for approximately $2.2bn in total equity value. Approved by both companies' boards of directors, the transaction is expected to close in the third quarter of 2026, con... Full story

Yahoo Finance • 2 months ago

argenx (ENXTBR:ARGX) Stock Looks Fairly Valued With Modest Upside On Earnings

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. argenx stock has delivered a very strong 202.6% return over the past five years, yet its current valuation checks poin... Full story

Yahoo Finance • 2 months ago

Top Biotech Gainers: GOSS To File Seralutinib NDA In Sep, OMER Gains On AZN's Loss, FBRX Acquired

(RTTNews) - Today's top biotech gainers include Entera Bio, following an oversubscribed private placement financing; Gossamer, which is progressing toward a planned Seralutinib NDA submission in September; First Tracks, which has been firi... Full story

Yahoo Finance • 2 months ago

Stocks making the biggest moves midday: ASML, SK Hynix, SAP, Forte Bio, Brown-Forman & more

Check out some of the companies making the biggest moves midday: ASML — The maker of semiconductor manufacturing equipment slid 8%. China began mass production of domestically made deep ultraviolet chipmaking tools, The Information reporte... Full story

Yahoo Finance • 2 months ago

Stocks making the biggest moves premarket: Micron Technology, Forte Biosciences, ExxonMobil, Baker Hughes & more

Check out the companies making the biggest moves premarket: Memory stocks — Shares rose broadly after chipmaker CXMT made its public market debut in Shanghai , with its stock skyrocketing more than 466%. The momentum carried over into U.S.... Full story